Journal of Vaccines & Vaccination

Point of care molecular diagnostic devices for detecting influenza infections

13^th Annual Congress on Vaccines, Therapeutics & Travel Medicine: Influenza & Infectious diseases

December 01-02, 2016 Atlanta, USA

Chi Lan Nguyen Vu

The University of Melbourne, Australia

Posters & Accepted Abstracts: J Vaccines Vaccin

Abstract:

Influenza infections are commonly associated with high morbidity and mortality. Conventional diagnostic methods often require professional laboratory scientists and specialized laboratory facilities. Therefore, these conventional diagnostic methods are often time consuming and quite expensive. Quick and rapid detection by the patientâ??s bedside can greatly improve the management of illness and reduce economic burden. A variety of point of care diagnostic devices has been developed to rapidly test for infectious diseases. One of them is an all polymer microfluidic system with a functionalized conductive polymer (PEDOT-OH:TsO) microelectrode array. It can detect influenza virus (H1N1) in less than 15 minutes. Another device called the Nanosphere Verigene platform got FDA approval for 5 infectious disease assays, including the respiratory virus plus (RV+ test). These devices produce accurate results and are simple to use. However, there is still a need to develop completely disposable devices that do not require equipment maintenance, lower the cost of these devices, monitor their accuracy in order to make these devices more widely available in the future.

Biography :

Email: chi_lilyvu@hotmail.com